The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy

AIMS: Glucagon-like peptide-1 receptor agonists are effective treatments for type 2 diabetes, effectively lowering glucose without weight gain and with low risk for hypoglycemia. However, their influence on the retinal neurovascular unit remains unclear. In this study, we analyzed the effects of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Oezer, Kuebra, Kolibabka, Matthias, Gassenhuber, Johann, Dietrich, Nadine, Fleming, Thomas, Schlotterer, Andrea, Morcos, Michael, Wohlfart, Paulus, Hammes, Hans-Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520173/
https://www.ncbi.nlm.nih.gov/pubmed/37423944
http://dx.doi.org/10.1007/s00592-023-02135-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520173/
https://www.ncbi.nlm.nih.gov/pubmed/37423944
http://dx.doi.org/10.1007/s00592-023-02135-7

Ejemplares similares